학술논문
Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective
Document Type
Article
Author
Source
In: Lupus . (Lupus, April 2022, 31(4):424-432)
Subject
Language
English
ISSN
14770962
09612033
09612033